News

In case you missed them, here are our top 5 articles for the week of May 21, 2017.

In the recent installment of the series, “We Were There,” the Centers for Disease Control and Prevention share what they have learned since the 1993 Escherichia coli (E. coli) outbreak.

The lack of availability of generic DAAs in many other parts of the world increases prices and often limits treatment to people with later stages of the disease.

The quality improvement group at the UNC Infectious Disease Clinic has come up with a process to increase rates of STD screening that includes providing patients with the option to self-swab.

After 3 individuals test positive for the mosquito-borne virus in Gujarat, WHO confirms that the Zika virus is currently circulating in the country.

Research published in Nature on May 24, suggests that the Zika virus has been circulating in the Americas silently for far longer than previously thought.

The key to meeting the Joint United Nations Program on HIV and AIDS (UNAIDS) benchmark may be to combine discrete areas of research into a more cohesive strategy.

Researchers from the University of Toronto evaluated 82 patients under 18 years of age from Toronto, Ottawa, Montreal, and Quebec.

An outbreak associated with a rare, paralytic illness has hospitalized several individuals and claimed one life thus far.

As health departments around the country continue to report new West Nile virus activity, a new study explores how the brain protects itself from this and other mosquito-borne viruses.

Physicians call for more education for themselves and the patient before recommending the use of topical microbicides.

Lyme Disease Association President, Pat Smith, takes on the major problems surrounding Lyme disease today.

While the 2016 Ebola outbreak in the Democratic Republic of Congo continues to unfold, researchers have identified the first natural human antibodies against all three major disease-causing ebolaviruses.

Researchers believe that an increased incidence of C. difficile in travelers returning from international destinations may be linked to travelers' diarrhea.

At the 2017 Annual Pediatric Academic Societies meeting, Gail Bolan, MD, from the CDC, explained why trends in STD reporting in 2015 may be disturbing.

Yemen has been hit by a resurgent cholera outbreak and health officials are focusing all of their efforts into infection control.

Researchers from Beaumont hospital have developed a Zika virus diagnostic test that yields quick results. In addition, a Zika vaccine may be coming our way, but perhaps not in the way we hoped.

A study conducted in France found that many pediatrics patients in the western region of the country are dying of vaccine-preventable diseases, and not because they’re not receiving vaccination.

In a research panel at the 2017 Annual Pediatric Academic Societies Meeting, Andres Camacho-Gonzalez, MD, and Craig Wilson, MD, discussed how poorly-controlled HIV infections in adolescents are related to increased risk of other STIs.

In case you missed them, here are our top 5 articles for the week of May 14, 2017.

Researchers at Houston Methodist Hospital have identified that a surprising percentage of Klebsiella pneumoniae infections at their facility are caused by uncommon strains of the pathogen.

On Hepatitis Testing Day, healthcare providers and the public work together to promote awareness and encourage those at risk to get tested.

Researchers from Stanford University use mechanistic models to predict the temperatures at which mosquitoes are likely to contract Zika and other arboviral diseases and transmit them to humans.

In a time of hunger games-style scientific funding, one researcher speaks out.

A new study finds that gay African American and Latino men who use multiple forms of technology to find sexual partners have higher rates of disease transmission.

Researchers from Montefiore Medical Center presented findings on differential diagnosis of MRSA and Staphylococcus aureus at the 2017 Annual Pediatric Academic Societies (PAS) meeting in San Francisco, California.

On HIV Vaccine Awareness Day, we reflect on the advancements made in the fight against HIV and the ongoing efforts to reach the collective goal of developing a safe, effective vaccine.

In a Phase 2 controlled clinical study, patients with Clostridium difficile infection receiving ridinilazole were found to have achieved better treatment outcomes than those receiving vancomycin.